Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27586 | 226 | 38.8 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
465 | 3 | RENAL CELL CARCINOMA//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS | 24387 |
318 | 2 | RENAL CELL CARCINOMA//PARTIAL NEPHRECTOMY//KIDNEY NEOPLASMS | 18306 |
27586 | 1 | BAP1//SETD2//BRCA1 ASSOCIATED PROTEIN 1 | 226 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BAP1 | authKW | 3514220 | 23% | 51% | 51 |
2 | SETD2 | authKW | 1087322 | 6% | 62% | 13 |
3 | BRCA1 ASSOCIATED PROTEIN 1 | authKW | 827561 | 3% | 88% | 7 |
4 | PBRM1 | authKW | 540441 | 4% | 50% | 8 |
5 | BAP1 PROTEIN | authKW | 405337 | 1% | 100% | 3 |
6 | SYDNEY VITAL TRANSLAT | address | 374151 | 3% | 46% | 6 |
7 | BAP1 CANCER SYNDROME | authKW | 270225 | 1% | 100% | 2 |
8 | HUASHAN UROL | address | 270225 | 1% | 100% | 2 |
9 | MBAITS | authKW | 270225 | 1% | 100% | 2 |
10 | H2AK119UB1 | authKW | 180148 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1963 | 48% | 0% | 109 |
2 | Genetics & Heredity | 569 | 22% | 0% | 49 |
3 | Pathology | 497 | 14% | 0% | 31 |
4 | Cell Biology | 447 | 24% | 0% | 54 |
5 | Urology & Nephrology | 80 | 6% | 0% | 14 |
6 | Biochemistry & Molecular Biology | 80 | 19% | 0% | 44 |
7 | Dermatology | 60 | 4% | 0% | 10 |
8 | Respiratory System | 8 | 2% | 0% | 5 |
9 | Hematology | 4 | 2% | 0% | 5 |
10 | Medicine, Research & Experimental | 1 | 2% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SYDNEY VITAL TRANSLAT | 374151 | 3% | 46% | 6 |
2 | HUASHAN UROL | 270225 | 1% | 100% | 2 |
3 | ABORAT INNOVAT CHEM LIFE SCIJIANGSU ENGN | 135112 | 0% | 100% | 1 |
4 | ABT KREBSGENOMFOR | 135112 | 0% | 100% | 1 |
5 | BIOL CELLULAIRE MOL CONTROLE PROFERAT | 135112 | 0% | 100% | 1 |
6 | CANC GASTR PANCREAT SURG | 135112 | 0% | 100% | 1 |
7 | CANC GENERT | 135112 | 0% | 100% | 1 |
8 | CANC MED ISRAEL CANADA | 135112 | 0% | 100% | 1 |
9 | CIC SANTE RECH MED 1402 | 135112 | 0% | 100% | 1 |
10 | CLIN SCI SECT ONCOL PATHOL | 135112 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER GENETICS | 8169 | 2% | 1% | 5 |
2 | ONCOTARGET | 1849 | 6% | 0% | 13 |
3 | GENES CHROMOSOMES & CANCER | 1527 | 3% | 0% | 6 |
4 | NATURE GENETICS | 1329 | 3% | 0% | 7 |
5 | NATURE REVIEWS NEPHROLOGY | 1200 | 1% | 0% | 2 |
6 | CELL REPORTS | 656 | 2% | 0% | 4 |
7 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 638 | 1% | 0% | 3 |
8 | JOURNAL OF THORACIC ONCOLOGY | 449 | 1% | 0% | 3 |
9 | PATHOLOGY | 426 | 1% | 0% | 3 |
10 | HUMAN PATHOLOGY | 419 | 2% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BAP1 | 3514220 | 23% | 51% | 51 | Search BAP1 | Search BAP1 |
2 | SETD2 | 1087322 | 6% | 62% | 13 | Search SETD2 | Search SETD2 |
3 | BRCA1 ASSOCIATED PROTEIN 1 | 827561 | 3% | 88% | 7 | Search BRCA1+ASSOCIATED+PROTEIN+1 | Search BRCA1+ASSOCIATED+PROTEIN+1 |
4 | PBRM1 | 540441 | 4% | 50% | 8 | Search PBRM1 | Search PBRM1 |
5 | BAP1 PROTEIN | 405337 | 1% | 100% | 3 | Search BAP1+PROTEIN | Search BAP1+PROTEIN |
6 | BAP1 CANCER SYNDROME | 270225 | 1% | 100% | 2 | Search BAP1+CANCER+SYNDROME | Search BAP1+CANCER+SYNDROME |
7 | MBAITS | 270225 | 1% | 100% | 2 | Search MBAITS | Search MBAITS |
8 | H2AK119UB1 | 180148 | 1% | 67% | 2 | Search H2AK119UB1 | Search H2AK119UB1 |
9 | 3P21 LOSS SYNDROME | 135112 | 0% | 100% | 1 | Search 3P21+LOSS+SYNDROME | Search 3P21+LOSS+SYNDROME |
10 | BAP1 GERMLINE MUTATION | 135112 | 0% | 100% | 1 | Search BAP1+GERMLINE+MUTATION | Search BAP1+GERMLINE+MUTATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | RAI, K , PILARSKI, R , CEBULLA, CM , ABDEL-RAHMAN, MH , (2016) COMPREHENSIVE REVIEW OF BAP1 TUMOR PREDISPOSITION SYNDROME WITH REPORT OF TWO NEW CASES.CLINICAL GENETICS. VOL. 89. ISSUE 3. P. 285 -294 | 45 | 59% | 13 |
2 | ASCOLI, V , COZZI, I , VATRANO, S , IZZO, S , GIORCELLI, J , ROMEO, E , CARNOVALE-SCALZO, C , GRILLO, LR , FACCIOLO, F , VISCA, P , ET AL (2016) MESOTHELIOMA FAMILIES WITHOUT INHERITANCE OF A BAP1 PREDISPOSING MUTATION.CANCER GENETICS. VOL. 209. ISSUE 9. P. 381 -387 | 35 | 81% | 0 |
3 | WANG, A , PAPNEJA, A , HYRCZA, M , AL-HABEEB, A , GHAZARIAN, D , (2016) GENE OF THE MONTH: BAP1.JOURNAL OF CLINICAL PATHOLOGY. VOL. 69. ISSUE 9. P. 750 -753 | 24 | 83% | 2 |
4 | LIAO, LL , TESTA, JR , YANG, HF , (2015) THE ROLES OF CHROMATIN-REMODELERS AND EPIGENETIC MODIFIERS IN KIDNEY CANCER.CANCER GENETICS. VOL. 208. ISSUE 5. P. 206 -214 | 38 | 48% | 6 |
5 | PIVA, F , SANTONI, M , MATRANA, MR , SATTI, S , GIULIETTI, M , OCCHIPINTI, G , MASSARI, F , CHENG, L , ANTONIOLOPEZ-BELTRAN , SCARPELLI, M , ET AL (2015) BAP1, PBRM1 AND SETD2 IN CLEAR-CELL RENAL CELL CARCINOMA: MOLECULAR DIAGNOSTICS AND POSSIBLE TARGETS FOR PERSONALIZED THERAPIES.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 15. ISSUE 9. P. 1201 -1210 | 31 | 53% | 7 |
6 | TOGO, Y , YOSHIKAWA, Y , SUZUKI, T , NAKANO, Y , KANEMATSU, A , ZOZUMI, M , NOJIMA, M , HIROTA, S , YAMAMOTO, S , HASHIMOTO-TAMAOKI, T , (2016) GENOMIC PROFILING OF THE GENES ON CHROMOSOME 3P IN SPORADIC CLEAR CELL RENAL CELL CARCINOMA.INTERNATIONAL JOURNAL OF ONCOLOGY. VOL. 48. ISSUE 4. P. 1571 -1580 | 26 | 68% | 0 |
7 | NASU, M , EMI, M , PASTORINO, S , TANJI, M , POWERS, A , LUK, H , BAUMANN, F , ZHANG, YA , GAZDAR, A , KANODIA, S , ET AL (2015) HIGH INCIDENCE OF SOMATIC BAP1 ALTERATIONS IN SPORADIC MALIGNANT MESOTHELIOMA.JOURNAL OF THORACIC ONCOLOGY. VOL. 10. ISSUE 4. P. 565 -576 | 24 | 53% | 26 |
8 | BETTI, M , ASPESI, A , BIASI, A , CASALONE, E , FERRANTE, D , OGLIARA, P , GIRONI, LC , GIORGIONE, R , FARINELLI, P , GROSSO, F , ET AL (2016) CDKN2A AND BAP1 GERMLINE MUTATIONS PREDISPOSE TO MELANOMA AND MESOTHELIOMA.CANCER LETTERS. VOL. 378. ISSUE 2. P. 120 -130 | 28 | 53% | 2 |
9 | BAUMANN, F , FLORES, E , NAPOLITANO, A , KANODIA, S , TAIOLI, E , PASS, H , YANG, HN , CARBONE, M , (2015) MESOTHELIOMA PATIENTS WITH GERMLINE BAP1 MUTATIONS HAVE 7-FOLD IMPROVED LONG-TERM SURVIVAL.CARCINOGENESIS. VOL. 36. ISSUE 1. P. 76 -81 | 24 | 59% | 14 |
10 | JOSEPH, RW , KAPUR, P , SERIE, DJ , PARASRAMKA, M , HO, TH , CHEVILLE, JC , FRENKEL, E , PARKER, AS , BRUGAROLAS, J , (2016) CLEAR CELL RENAL CELL CARCINOMA SUBTYPES IDENTIFIED BY BAP1 AND PBRM1 EXPRESSION.JOURNAL OF UROLOGY. VOL. 195. ISSUE 1. P. 180 -187 | 14 | 70% | 9 |
Classes with closest relation at Level 1 |